Royce & Associates’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Sell |
81,499
-260
| -0.3% | -$8.22K | 0.03% | 564 |
|
|
2025
Q1 | $2.71M | Hold |
81,759
| – | – | 0.03% | 546 |
|
|
2024
Q4 | $2.81M | Buy |
81,759
+3,056
| +4% | +$105K | 0.03% | 576 |
|
|
2024
Q3 | $3.15M | Sell |
78,703
-11,413
| -13% | -$457K | 0.03% | 557 |
|
|
2024
Q2 | $2.72M | Sell |
90,116
-8,122
| -8% | -$245K | 0.03% | 582 |
|
|
2024
Q1 | $3.3M | Sell |
98,238
-11,365
| -10% | -$382K | 0.03% | 564 |
|
|
2023
Q4 | $3.54M | Sell |
109,603
-170,746
| -61% | -$5.52M | 0.03% | 564 |
|
|
2023
Q3 | $9.19M | Buy |
280,349
+60,770
| +28% | +$1.99M | 0.09% | 317 |
|
|
2023
Q2 | $7.73M | Sell |
219,579
-112,750
| -34% | -$3.97M | 0.08% | 383 |
|
|
2023
Q1 | $10.9M | Buy |
332,329
+102,059
| +44% | +$3.33M | 0.11% | 284 |
|
|
2022
Q4 | $12.7M | Sell |
230,270
-65,740
| -22% | -$3.62M | 0.13% | 228 |
|
|
2022
Q3 | $13.1M | Buy |
296,010
+27,813
| +10% | +$1.23M | 0.15% | 199 |
|
|
2022
Q2 | $13.1M | Buy |
268,197
+12,390
| +5% | +$604K | 0.13% | 222 |
|
|
2022
Q1 | $12.4M | Buy |
255,807
+36,723
| +17% | +$1.79M | 0.11% | 290 |
|
|
2021
Q4 | $9.34M | Sell |
219,084
-10,306
| -4% | -$439K | 0.07% | 410 |
|
|
2021
Q3 | $8.79M | Buy |
229,390
+101,340
| +79% | +$3.88M | 0.07% | 457 |
|
|
2021
Q2 | $3.62M | Buy |
+128,050
| New | +$3.62M | 0.02% | 665 |
|